Restored expression of fragile histidine triad protein and tumorigenicity of cervical carcinoma cells

被引:32
作者
Wu, R
Connolly, DC
Dunn, RL
Cho, KR
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Ctr Comprehens Canc, Biostat Core, Ann Arbor, MI 48109 USA
关键词
D O I
10.1093/jnci/92.4.338
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Allelic losses in the short arm of chromosome 3 are common in cervical carcinomas. The fragile histidine triad (FHIT) gene at chromosome region 3p14.2 is a candidate tumor suppressor gene that may play a role in cervical tumorigenesis. We and others have identified aberrant FHIT transcripts and frequent loss of Fhit protein expression in primary cervical cancers and high-grade noninvasive lesions but not in normal cervical tissues. The altered expression of FHIT may be due to somatic mutations or integration of human papillomavirus DNA at the FHIT locus. The purpose of this study was to determine whether ectopic expression of Fhit can suppress the tumorigenic properties of cervical cancer cells. Methods: We employed infection with recombinant retroviruses as well as transfection of plasmid DNA to restore Fhit protein expression in cervical cancer cell Lines lacking full-length FHIT transcripts and endogenous Fhit protein. The effects of Fhit expression on tumor cell morphology, anchorage-independent growth, and tumorigenicity in nude mice were examined. Results: Stable overexpression of Fhit had no discernible effect on the tumorigenic properties of two cervical carcinoma cell lines or on a lung carcinoma cell line previously reported by others to be suppressed for tumorigenicity by Fhit. Conclusions: Restoration of Fhit expression does not suppress anchorage-independent growth or tumorigenicity of cervical carcinoma cell lines. However, it remains possible that FHIT inactivation may be important early in cervical tumor progression or that FHIT may suppress tumorigenesis in ways distinct from those measured by the assays employed in this study.
引用
收藏
页码:338 / 344
页数:7
相关论文
共 34 条
[1]   Human papillomaviruses and associated malignancies [J].
Alani, RM ;
Münger, K .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :330-337
[2]   Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5'''-P-1,P-3-triphosphate hydrolase [J].
Barnes, LD ;
Garrison, PN ;
Siprashvili, Z ;
Guranowski, A ;
Robinson, AK ;
Ingram, SW ;
Croce, CM ;
Ohta, M ;
Huebner, F .
BIOCHEMISTRY, 1996, 35 (36) :11529-11535
[3]  
Birrer MJ, 1999, CANCER RES, V59, P5270
[4]   Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B [J].
Boldog, F ;
Gemmill, RM ;
West, J ;
Robinson, M ;
Robinson, L ;
Li, EF ;
Roche, J ;
Todd, S ;
Waggoner, B ;
Lundstrom, R ;
Jacobson, J ;
Mullokandov, MR ;
Klinger, H ;
Drabkin, HA .
HUMAN MOLECULAR GENETICS, 1997, 6 (02) :193-203
[5]  
Chu TY, 1998, INT J CANCER, V75, P199, DOI 10.1002/(SICI)1097-0215(19980119)75:2<199::AID-IJC6>3.0.CO
[6]  
2-P
[7]  
Druck T, 1997, CANCER RES, V57, P504
[8]  
Druck T, 1998, ONCOL RES, V10, P341
[9]  
Greenspan DL, 1997, CANCER RES, V57, P4692
[10]   The role of the FHIT/FRA3B locus in cancer [J].
Huebner, K ;
Garrison, PN ;
Barnes, LD ;
Croce, CM .
ANNUAL REVIEW OF GENETICS, 1998, 32 :7-31